Page 464 - Clinical Hematology_ Theory _ Procedures ( PDFDrive )
P. 464

448            PART 6  ■  Neoplastic Disorders




                         rkers,     st cells   n   n  rrow CD57+ cytotoxic    cells   s pre  ic-                           Steingri  s  ottir H, et   l. Monoclon  l g      op  thy: n  tur  l history

                     tors o  outco  e, Haematologica, 92(8):1075–1082, 2007.                                                     stu  ie   with    retrospective   ppro  ch, Haematologica, 92(8):1131–


                                            i
               Molin   A. Zev  lin™n NHL:    new   ppro  ch in the tre  t  ent o  NHL.                                           1134, 2007.
                     Satellite Symposium Presentation at the 8th Congress o  the European                                  Sti   P. Wh  t is the role o    utologous tr  nspl  nt  or ly  pho     in the
                     Hematology Association, Lyon, Fr  nce, June 12, 2003.                                                       current er  ? Hematology Am Soc Hematol Educ Program, 2015

               Qi  n J, et   l. Myelo     cell line-  erive  , poole   he  t shock proteins   s                                  :74–80, 2015.

                     univers  l v  ccine  or i    unother  py o    ultiple   yelo    , Blood,                              Stilgenb  uer S. Prognostic     rkers   n   st  n    r       n  ge  ent o  chro-
                     114(18):3880–3889, 2009.                                                                                      ic ly  phocytic leuke  i  , Hematology Am Soc Hematol Educ

               R  i KR, Chior  zzi N. Deter  ining the clinic  l course   n   outco  e in                                        Program, 2015:368–376, 2015.

                     chronic ly  phocytic leuke  i  , N Engl J Med, 348(18):1797–1799,                                      e  chey  D  .  So    tic  ALPS:      FAScin  ting  con  ition,  Blood,

                     2003.                                                                                                       115(25):5125–5126, 2010.
               R  jku    r  SV.  Evolving    i  gnostic  criteri     or    ultiple    yelo    ,                             i  cci E, et   l.     rgeting   ut  nt BRAF in rel  pse   or re r  ctory h  iry-

                     Hematology Am Soc Hematol Educ Program, 2015:272–278, 2015.                                                 cell leuke  i  , N Engl J Med, 373(18):1733–1746, 2015.

               Rogoski RR. Seru    ree light ch  in   ss  ys:   etecting pl  s     cell   isor-                            Vij  y  A,  Gertz  MA.  W  l  enströ        croglobuline  i  ,  Blood,

                      ers, Med Lab Observer, 41(7):10–21, 2009.                                                                  109(12):5096–5103, 2007.
               Rosenw  l   A. Bri  ging   olecul  r p  thology   n   clinics in ly  pho    .                               Willi    s H, Cr  w or   DH. Epstein-B  rr virus: the i  p  ct o  scientif c

                     In: E  uc  tion  l Roz    n C, Montserr  t E. Chronic ly  phocytic                                              v  nces on clinic  l pr  ctice, Blood, 107(3):862–869, 2006.

                     leuke  i  , N Engl J Med, 333(16):1052–1057, 1995.                                                    Winter JN, Peterson LC. Ly  phocytosis, ly  ph    enop  thy: benign or

               S  n-Miguel JF, et   l. Incorpor  ting novel   gents into up ront   yelo                                             lign  nt? Hematology Am Soc Hematol Educ Program, 2015:106–
                     ther  py, N Engl J Med, 359:906–917, 2008.                                                                  110, 2015.

               S  n  ers PW. A new twist in   yelo     tre  t  ent, Blood, 107(2):413–414,                                 Woy  ch JA. P  tterns o  resist  nce to B cell-receptor p  thw  y   nt  go-

                     2006.                                                                                                       nists in chronic ly  phocytic leuke  i     n   str  tegies  or     n  ge-

               Sieg  l D, et   l. Seru    ree light ch  in   n  lysis  or   i  gnosis,   onitoring,                               ent, Hematology Am Soc Hematol Educ Program, 2015:355–360,
                       n   prognosis o    onoclon  l g      op  thies, Lab Med, 40(6):363–                                       2015.

                     367, 2009.                                                                                            Zent CS.   i  e to test CLL p53  unction, Blood, 115(21):4154, 2010.
   459   460   461   462   463   464   465   466   467   468   469